Premium Information is available for this item - Upgrade for $1 a day

6505-01-232-3117

Oxtriphylline And Guaifenesin Elixir

6505012323117 012323117 BRONDECON ELIRIX NDC00071-2201-23

INC: 27209 Oxtriphylline And Guaifenesin Elixir

6505-01-232-3117 OXTRIPHYLLINE AND GUAIFENESIN ELIXIR 6505012323117 012323117

Managed by United States
NSN Created on 10 May 1986
Data Last Changed
January 2023
NATO Update Count
3
NATO Data Quality
6505-01-232-3117 OXTRIPHYLLINE AND GUAIFENESIN ELIXIR 6505012323117 012323117 1/1
NSN 6505-01-232-3117 (Generic Image) 1/1

6505-01-232-3117 Stock and Availability Marketplace 6505-01-232-3117

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-232-3117 RQST NE eBay
eBay Updated Every Day
6505-01-232-3117 RQST eBay
Amazon Updated Every Day
6505-01-232-3117 RQST NE Amazon

6505-01-232-3117 Related Documents Related Documents 6505-01-232-3117 3+ Documents (More...)

BRONDECON ELIRIX NDC00071-2201-23 Managed by United States NSN Created on 10 May 1986 Data Last Changed
RQST NE Updated Every Day 6505-01-232-3117 RQST Updated Every Day 6505-01-232-3117 RQST NE Related Documents
6505-01-232-3117 3+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-232-3117
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-880-4948 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-232-3117
Guaifenesin Elixir your Account Upgrade 6505-01-232-3117Oxtriphylline And Guaifenesin Elixir6505012323117 012323117
BRONDECON https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-232-3117 Oxtriphylline And Guaifenesin
www.nsnlookup.com /fsg-76/fsc-7643/us 7643-01-405-1978 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-232-3117
Oxtriphylline And Guaifenesin Elixir -01-232-3117Oxtriphylline And Guaifenesin Elixir6505012323117 012323117
BRONDECON ELIRIX NDC00071-2201-23 fsg-65/fsc-6505/us 6505-01-232-3117 Oxtriphylline And Guaifenesin

6505-01-232-3117 Demil Restrictions 6505-01-232-3117

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: Y | PMIC: U | EDC: | ADPEC:

6505-01-232-3117 is a Oxtriphylline And Guaifenesin Elixir that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). The precious metals content of this item is unknown.

6505-01-232-3117 HTS and ScheduleB Import and Export 6505-01-232-3117

6505-01-232-3117 End Users End Users 6505-01-232-3117

MOE Rule:
V542
Effective Date:
1 Apr 1991

6505-01-232-3117 Manufacturers Approved Sources 6505-01-232-3117

6505-01-232-3117 Technical Data Datasheet 6505-01-232-3117

Characteristic
Specifications
FIIG
A45100
Active Medicament Medicinal Strength [AKJA]
20.000 Milligrams Choline Theophyllinate Per Milliliter And 10.000 Milligrams Guaifenesin Per Milliliter
Administration [CSGS]
Oral
Flavor [ALJH]
Cherry
Primary Container Content Quantity [CRLK]
16.000 Ounces
Primary Container Type [CQCT]
Bottle
Therapeutic Equivalent [THPE]
Not Rated

6505-01-232-3117 Management Data Management Data 6505-01-232-3117

Effective Date
Organization
Unit of Issue
Unit Price
Qty Unit Pack
May 1986
Veterans Administration (VA)
BT
Subscribe
MOE
USC
Code
Statement
Order of Use
Jump To Code
Qty Per Assy
UOM
Technical Document
Quantative Expression
Veterans Administration (VA)
V
K
U/I Contains 16 Oz
00000000016OZ

6505-01-232-3117 Similar Items Similar Supply Items to 6505-01-232-3117

6505-01-232-3117 Freight Data Freight Information 6505-01-232-3117

6505-01-232-3117 has freight characteristics.. 6505-01-232-3117 has a variance between NMFC and UFC when transported by rail and the description should be consulted.